Temporal Lobe Epilepsy

Abstract

Temporal lobe epilepsy is the most common focal epilepsy in adults, a condition in which recurrent seizures arise from the medial temporal lobe — most often from a scarred, shrunken hippocampus. A mesial temporal seizure typically begins as a focal aware seizure with a rising epigastric sensation, a taste of fear, or a flush of deja vu, then spreads to impair awareness and can generalise into a convulsion. It belongs to cognitive psychology because the tissue that generates the seizures is also the seat of declarative memory, so that both the disease and its surgical cure exact a memory cost. The first randomised trial of surgery showed anterior temporal lobectomy far superior to continued medication, reshaping treatment and turning the memory trade-off into a measurable clinical decision.

Keywords: temporal lobe epilepsy, hippocampal sclerosis, declarative memory, focal seizure, epilepsy surgery

Temporal lobe epilepsy (TLE) is a chronic condition in which recurrent, unprovoked seizures originate in the temporal lobe, and it is the most common form of focal epilepsy in adults (Devinsky et al., 2018). In its commonest form the seizures arise not from the outer temporal cortex but from the medial structures — the hippocampus, amygdala, and entorhinal cortex — and the hippocampus itself is typically scarred and shrunken, a lesion called hippocampal sclerosis that is at once the seizure focus and the largest single pathology found in adult epilepsy surgery (Blumcke et al., 2017). What makes TLE a subject for cognitive psychology, and not neurology alone, is the coincidence at its heart: the medial temporal lobe that generates the seizures is the same tissue that binds new experience into lasting declarative memory, so that the disease, and the surgery that most reliably cures it, both press directly on the machinery of memory (Squire, 2004).

What Temporal Lobe Epilepsy Is

Temporal lobe epilepsy is a focal (partial) epilepsy — one in which seizures start in a circumscribed part of one hemisphere rather than engaging the whole brain at once — whose seizure focus lies in the temporal lobe (Fisher et al., 2017). Epilepsy itself is defined by a lasting predisposition to recurrent, unprovoked seizures, and among the focal epilepsies of adulthood TLE is the most common and the most often referred for surgery (Devinsky et al., 2018). It is a syndrome with a characteristic anatomy, a characteristic pathology, and a characteristic seizure, and holding those three apart clarifies the condition.

The defining pathology of the commonest form is hippocampal sclerosis: a loss of neurons and a hardening scar (gliosis) concentrated in specific hippocampal subfields, leaving the structure visibly shrunken on MRI and microscopically reorganised (Thom, 2014). In the largest histopathological series of epilepsy surgery specimens, mesial temporal sclerosis was the single most frequent diagnosis in adults, underlining that TLE is not an abstraction but a tissue lesion one can hold on a slide (Blumcke et al., 2017). An international consensus classification now sorts that lesion into defined subtypes by which subfields are lost, because the pattern predicts how well surgery will control the seizures (Blumcke et al., 2013).

TLE is conventionally divided by *where* in the temporal lobe the seizures begin. The two forms differ in their auras, their usual causes, and their surgical targets (Table 1).

Table 1

Two Anatomical Forms of Temporal Lobe Epilepsy

How a Seizure Starts in the Temporal Lobe

A mesial temporal seizure runs a stereotyped course, and the modern seizure classification names its stages precisely (Fisher et al., 2017). It begins as a *focal aware seizure* — the older term was *simple partial* — in which a small population of neurons in the medial temporal lobe discharges abnormally while the person remains fully conscious. What they feel is the aura: most characteristically a sensation rising from the stomach to the chest, but often a sudden flood of deja vu, an unwarranted fear, or a phantom smell — subjective experiences that are themselves the first symptom of the discharge, not a warning that precedes it.

As the discharge recruits more of the temporal lobe and its connections, the seizure becomes a *focal impaired-awareness seizure* (formerly *complex partial*): the person stops, stares, and typically performs automatisms — lip-smacking, chewing, fumbling with the hands — of which they will have no memory afterwards, because the very structures that would record the episode are seizing (Devinsky et al., 2018). If the discharge then propagates to both hemispheres it becomes a *focal-to-bilateral tonic-clonic seizure*, the convulsion that a lay observer recognises as a seizure. The path from a private aura to a bilateral convulsion is a spread across a network, and mapping that network — with stereo-EEG electrodes placed inside the brain, and with signal analysis of how the discharge propagates — is now central to deciding what tissue must be removed to stop the seizures (Bartolomei et al., 2017).

The Cognitive Cost of a Temporal Focus

The distinctive cost of temporal lobe epilepsy is a cost to memory, and it follows directly from where the seizures live. The medial temporal lobe — hippocampus and adjacent cortex — is the structure that consolidates experience into new lasting declarative memories, the founding lesson of the patient H.M., who became densely amnesic after both medial temporal lobes were removed to control his epilepsy (Scoville & Milner, 1957). That single case established the medial temporal lobe as critical for forming new memories, and it is precisely that system which TLE inflames and scars (Squire, 2004).

The result is a measurable, often progressive, memory impairment. Longitudinal study of adults with chronic TLE shows genuine cognitive decline over years, with the memory loss tracking the duration and severity of the epilepsy — the seizures and the underlying sclerosis exact an ongoing toll rather than a fixed one-time deficit (Helmstaedter et al., 2003). The impairment is also *material-specific*, splitting along the brain's division of labour for language: a focus in the language-dominant temporal lobe (usually the left) tends to impair verbal memory — names, words, spoken facts — while a focus in the non-dominant (usually right) temporal lobe tends to impair memory for faces, routes, and spatial layouts. This lateralisation is not a footnote; it is the pivot of the surgical decision, because removing the sclerotic focus risks removing whatever memory function that side still supports.

Worked Example

The landmark event in the treatment of temporal lobe epilepsy was the first randomised controlled trial of surgery, which let the benefit be stated as a single number a clinician can act on (Wiebe et al., 2001). In that trial, patients with drug-resistant TLE were randomised either to anterior temporal lobectomy or to continued medical therapy, and the outcome was freedom from the seizures that impair awareness at one year. In the surgical group $58\%$ became free of those seizures; in the medical group only $8\%$ did. The *absolute risk reduction* (ARR) is the difference in these success rates, and the *number needed to treat* (NNT) — how many patients must undergo surgery for one additional patient to become seizure-free — is its reciprocal:

$$\text{ARR} = p_\text{surgery} - p_\text{medical} = 0.58 - 0.08 = 0.50$$

$$\text{NNT} = \frac{1}{\text{ARR}} = \frac{1}{0.50} = 2$$

An NNT of $2$ is extraordinarily small for any medical intervention: it means that for roughly every two patients with drug-resistant mesial TLE who undergo surgery, one who would otherwise have kept having disabling seizures becomes free of them. That single figure overturned decades of therapeutic caution and established surgery as the treatment of choice for drug-resistant TLE, a conclusion later reinforced by a randomised trial of *early* surgery (Engel, 2012) and by long-term cohort data showing that many operated patients remain seizure-free for a decade or more (de Tisi et al., 2011). The number is a genuine average, not a guarantee for any one person, and it must be weighed against the memory cost of removing the focus — which is exactly why the lateralisation of memory, not the seizure count alone, governs who is offered surgery.

Discussion

The scientific interest of temporal lobe epilepsy for cognitive psychology lies in a coincidence of anatomy that turns a disease into a natural experiment. The medial temporal lobe is simultaneously the commonest source of adult focal seizures and the indispensable engine of declarative memory, so TLE and its treatment probe the memory system from two directions at once: the disease degrades memory through chronic seizures and sclerosis (Helmstaedter et al., 2003), and the cure degrades it further by resecting the very tissue H.M.'s case first identified as critical (Scoville & Milner, 1957). The condition is therefore a standing reminder that the brain's functions are localised, that removing tissue removes function, and that clinical decisions in this region are irreducibly trade-offs.

The three demonstrations on this page track that logic. The seizure-spread display shows how a discharge in the mesial focus escalates from a private aura through impaired awareness to a bilateral convulsion; the surgical-outcome tool lets the reader recompute the number needed to treat from the trial's seizure-freedom rates; and the memory-lateralisation display shows how a left-sided and a right-sided focus impair different kinds of memory, and why that side determines the risk of surgery. What remains genuinely open is the definition and prediction of the epileptogenic *network* — the extended web of tissue that must be removed or disconnected to stop seizures — which modern stereo-EEG and signal analysis are still working to delineate (Bartolomei et al., 2017).

Cognitive Implications

The deepest implication of TLE for cognition is that memory is not a single faculty housed in one place but a set of material-specific functions divided between the hemispheres, and epilepsy surgery is the setting in which that division becomes a live clinical fact. Because a left temporal focus threatens verbal memory and a right temporal focus threatens visuospatial memory, the pre-surgical work-up must establish which hemisphere is dominant for language and how much memory each side still carries, so that removing the seizure focus does not inadvertently remove a patient's capacity to remember words or faces (Squire, 2004).

TLE also reframes what a seizure *is* for cognitive psychology. The aura of mesial temporal epilepsy — the deja vu, the rising fear, the sudden certainty of familiarity — is not a preliminary to the seizure but a direct read-out of abnormal activity in the structures that normally generate feelings of familiarity, emotional salience, and autobiographical recollection (Devinsky et al., 2018). That a discharge in the hippocampus and amygdala should feel like *remembering* tells us these experiences are computations that specific tissue performs, computations that can be triggered pathologically by the same current that, spreading further, abolishes consciousness altogether.

Current Directions

Two research fronts are especially active. The first is the drive to define drug resistance early and to intervene sooner. The recognition that patients who fail two appropriate medications are unlikely to be controlled by a third — the operational definition of drug-resistant epilepsy — means such patients can be referred for surgical evaluation without years of futile trials (Kwan & Brodie, 2000), and the trial of early surgery pushed that logic further by showing benefit when surgery is offered soon after resistance is established rather than after decades of seizures (Engel, 2012). Randomised evidence now extends the case for surgery into childhood, where controlling seizures early may protect the developing brain (Dwivedi et al., 2017).

The second front is mechanistic: understanding how a hippocampus becomes and stays epileptic. Neuroinflammation has emerged as an active driver rather than a bystander, with inflammatory signalling in the sclerotic hippocampus now studied both as a cause of continuing seizures and as a target for new treatments and biomarkers (Vezzani et al., 2019). Alongside this, the systematic classification of the epilepsies and of hippocampal sclerosis into defined subtypes is sharpening prognosis, since which subfields are lost predicts how completely surgery will control the seizures (Scheffer et al., 2017), (Blumcke et al., 2013), and long-term outcome studies continue to refine who benefits and for how long (Tellez-Zenteno et al., 2005), (Schuele & Luders, 2008).

Common Misconceptions

A temporal lobe seizure always means a convulsion.

No. Most mesial temporal seizures are focal seizures with a rising sensation, deja vu, or a staring spell with automatisms; awareness is impaired but the body does not convulse. Only when the discharge spreads to both hemispheres does it become a bilateral tonic-clonic convulsion (Fisher et al., 2017).

Epilepsy surgery is a last resort of desperation.

For drug-resistant mesial TLE, surgery is the most effective treatment, not a gamble. The first randomised trial found a number needed to treat of about two, and guidelines now recommend early referral rather than prolonged medication trials (Wiebe et al., 2001).

The aura is a warning that comes before the seizure.

The aura is the seizure — its earliest, focal-aware phase. The deja vu or rising sensation is the first symptom of the abnormal discharge itself, not a separate signal preceding it (Devinsky et al., 2018).

Removing the temporal lobe has no cognitive downside.

Because the focus is the memory system, resection carries a real memory cost, especially for verbal memory when the language-dominant side is operated. This is why lateralisation of language and memory, not seizures alone, governs the surgical decision (Scoville & Milner, 1957).

Glossary

Absolute risk reduction (ARR).

The difference between two success (or event) rates; here, the surgical seizure-freedom rate minus the medical rate. Its reciprocal is the number needed to treat.

Amygdala.

An almond-shaped medial temporal-lobe structure that assigns emotional significance; its discharge contributes the fear and emotional colour of a mesial temporal aura.

Anterior temporal lobectomy.

Surgical removal of the front part of the temporal lobe, including the sclerotic hippocampus; the operation shown by randomised trial to control drug-resistant mesial TLE.

Aura.

The subjective first phase of a focal seizure, experienced while awareness is intact; in mesial TLE typically a rising epigastric sensation, deja vu, fear, or a phantom smell.

Automatism.

A repetitive, purposeless movement — lip-smacking, chewing, fumbling — performed during a focal impaired-awareness seizure and not remembered afterwards.

Declarative memory.

Memory for facts and events that can be consciously recalled; consolidated by the medial temporal lobe and the function most at risk in TLE and its surgery.

Deja vu.

A sudden, unwarranted sense that a present moment has been experienced before; a common mesial temporal aura and a read-out of abnormal familiarity signalling.

Drug-resistant epilepsy.

Epilepsy not controlled after adequate trials of two appropriate medications; the threshold at which surgical evaluation becomes appropriate.

Focal seizure.

A seizure originating in one circumscribed region of one hemisphere; may be aware or impaired-awareness, and may spread to become bilateral tonic-clonic.

Hippocampal sclerosis.

Loss of neurons and gliotic scarring in specific hippocampal subfields, leaving the structure shrunken; the defining pathology of the commonest form of TLE.

Hippocampus.

A curved medial temporal-lobe structure essential to forming new declarative memories; its scarring (hippocampal sclerosis) is the commonest focus of mesial TLE.

Material-specific memory.

The division of memory by content between the hemispheres: verbal memory in the language-dominant (usually left) temporal lobe, visuospatial memory in the non-dominant (usually right).

Mesial temporal lobe.

The inner surface of the temporal lobe, housing hippocampus, amygdala, and entorhinal cortex; the origin of the commonest form of TLE.

Number needed to treat (NNT).

How many patients must receive a treatment for one additional good outcome; the reciprocal of the absolute risk reduction. For surgery in drug-resistant TLE it is about two.

Stereo-EEG (SEEG).

Recording from depth electrodes placed inside the brain to map where a seizure begins and how it spreads, defining the epileptogenic network before surgery.

Tonic-clonic seizure.

A convulsion with stiffening (tonic) then rhythmic jerking (clonic) phases; in TLE it arises when a focal discharge spreads to both hemispheres.

Key Researchers

Ingmar Blumcke

German neuropathologist who led the ILAE task force defining the international consensus classification of hippocampal sclerosis and the large European brain-bank histopathology series, fixing the modern criteria for the lesion underlying most mesial TLE. ORCID

Jerome Engel

American neurologist and epileptologist who defined mesial temporal lobe epilepsy as a distinct surgically-remediable syndrome, developed the widely used scale for post-surgical seizure outcome, and led the randomised trial of early surgery for drug-resistant mesial TLE. ORCID

Brenda Milner

British-Canadian neuropsychologist whose study of the patient H.M. — densely amnesic after a bilateral medial-temporal resection for epilepsy — established the hippocampus and medial temporal lobe as critical for forming new declarative memories, the founding evidence for the memory system that TLE disturbs. Wikidata

Wilder Penfield

Canadian-American neurosurgeon who founded the Montreal Neurological Institute and pioneered surgery for focal epilepsy, mapping the exposed cortex of awake patients to localise the seizure focus; his stimulation of the temporal lobe famously evoked vivid experiential flashbacks, linking the region to memory and epilepsy. Wikidata

Ingrid Scheffer

Australian paediatric neurologist and epilepsy geneticist who co-chaired the ILAE commission behind the modern classification of the epilepsies and identified genes underlying many epilepsy syndromes. ORCID

Maria Thom

British neuropathologist specialising in the pathology of epilepsy, whose reviews of hippocampal sclerosis synthesise the cell-loss and reorganisation patterns that define the mesial temporal lesion and predict surgical outcome. ORCID

Samuel Wiebe

Canadian neurologist and clinical epidemiologist who led the first randomised controlled trial of surgery for temporal lobe epilepsy, showing anterior temporal lobectomy markedly superior to continued medical therapy. ORCID

Frequently Asked Questions

What is temporal lobe epilepsy?

It is a chronic condition in which recurrent, unprovoked seizures originate in the temporal lobe. It is the most common focal epilepsy in adults, and in its commonest form the seizures arise from the medial temporal structures, above all the hippocampus and amygdala.

What is hippocampal sclerosis?

It is a loss of neurons and scarring concentrated in specific parts of the hippocampus, leaving it shrunken and reorganised. It is the defining pathology of the commonest form of TLE and, in surgical series, the single most frequent diagnosis in adults.

What does a temporal lobe seizure feel like?

It usually begins with an aura felt while the person is still aware: a rising sensation in the stomach, a wave of deja vu, sudden fear, or a phantom smell. Awareness may then be impaired, with staring and automatisms such as lip-smacking, of which the person keeps no memory.

Why does temporal lobe epilepsy affect memory?

Because the medial temporal lobe that generates the seizures is the same tissue that consolidates new declarative memories. Chronic seizures and the underlying sclerosis degrade memory over time, and the effect is material-specific to the side of the focus.

Is surgery effective?

Yes. The first randomised trial found that surgery made most patients with drug-resistant TLE seizure-free at one year, against very few on medication alone, a number needed to treat of about two. Later trials and long-term follow-up confirmed the benefit.

Does surgery carry a cognitive risk?

Yes. Removing the seizure focus removes functioning memory tissue, so verbal memory is at risk when the language-dominant (usually left) side is operated, and visuospatial memory when the non-dominant side is. This is why memory and language lateralisation are assessed before surgery.

What is drug-resistant epilepsy?

It is epilepsy that remains uncontrolled after adequate trials of two appropriate medications. Reaching this threshold means a third drug is unlikely to help and is the point at which surgical evaluation should be considered.

What is the difference between mesial and lateral temporal lobe epilepsy?

Mesial TLE arises from the inner temporal structures and is usually caused by hippocampal sclerosis, with auras of rising sensation or deja vu. Lateral (neocortical) TLE arises from the outer temporal cortex, is more often caused by a structural lesion, and tends to produce auditory or visual auras.

Support Organizations

References